RISA KAGAN, M.D,

Plain English
This study looked at how common the Hepatitis Delta virus (HDV) is in people in the U.S. who are also infected with the Hepatitis B virus. It found that about 2.2% of these individuals tested positive for HDV, with 28% of those having a detectable amount of the virus in their blood. Understanding the prevalence of HDV is important because better testing can help identify people who may need treatment for this virus, improving their health outcomes. Who this helps: Patients with Hepatitis B who might also have HDV.

Plain English
This study looked at how the resistance of the HIV-1 virus to certain drugs has changed from 2018 to 2024, focusing on both RNA and DNA forms of the virus. The researchers found that drug resistance declined overall, with resistance to a specific combination of drugs dropping from 6.1% to 3.5% for RNA samples, and from 12.1% to 7.8% for DNA samples. This matters because it indicates that newer treatment options are helping to make HIV more manageable and effective treatments more available. Who this helps: Patients living with HIV.

Plain English
This study looked at a fast and accurate method to identify different versions of the SARS-CoV-2 virus, which causes COVID-19. Researchers compared a new testing method, called RT-PCR, to the traditional whole-genome sequencing (WGS) method. They found that the RT-PCR method correctly identified virus variants 100% of the time for key mutations and was able to detect variants like Delta and Omicron almost as well as WGS, helping to quickly manage and understand COVID-19 infections. Who this helps: This benefits patients and healthcare providers by allowing for quicker and more accessible testing for COVID-19 variants.

Plain English
Researchers developed a faster, more efficient way to read the complete genetic code of the COVID-19 virus directly from patient samples, allowing a single lab to analyze nearly 2,700 samples at once instead of just a few. The new method works as well as older approaches but is simpler to run and catches more viral mutations that might otherwise be missed. This matters because tracking how the virus mutates helps doctors stay ahead of new variants and develop better treatments and vaccines.

Plain English
Researchers studied the effectiveness of self-collected nasal swabs for testing COVID-19 (SARS-CoV-2) to see if this method would be as reliable as tests done by health workers. They found that among nearly 48,000 participants, only 1.8% tested positive for COVID-19, and the testing method produced very few false negatives. This matters because it shows that self-collection is a safe and reliable way to test for the virus, which can help reduce health risks and reliance on personal protective equipment. Who this helps: This benefits patients and healthcare providers by making testing more accessible and safer.

Plain English
This study evaluated how different types of transport media and storage conditions affect the stability of the SARS-CoV-2 virus in samples used for testing. Researchers tested five different transport media and various sample types, finding that the virus's RNA remained stable across multiple storage temperatures for up to 14 days. This is important because it shows that alternative media and temperature conditions can be used effectively for transporting COVID-19 samples, helping to ensure testing can continue even when resources are limited. Who this helps: This benefits doctors and laboratories conducting COVID-19 testing, particularly in situations where transport media is scarce.

Plain English
This study looked at whether combining samples from multiple people—called specimen pooling—could safely increase the number of COVID-19 tests that can be processed at once. The researchers found that pooling five samples together resulted in accurate test results 100% of the time, even in low-prevalence situations where only a few people are positive for the virus. This is important because it means testing more people quickly without losing accuracy, which can help in controlling the spread of COVID-19. Who this helps: This helps patients and healthcare systems by making COVID-19 testing faster and more efficient.

Plain English
The study examined trends in drug resistance mutations for HIV-1 from 2006 to 2017 using data from a large U.S. laboratory. It found that the overall rate of resistance to certain older HIV treatments decreased from 48.9% to 39.3%, while instances of resistance to newer therapies increased. Specifically, high-level resistance dropped significantly from 43.3% in 2006 to 17.1% in 2017. This is important because understanding these trends can help doctors tailor treatment plans and decide when to conduct resistance testing. Who this helps: Patients living with HIV.

Plain English
In a study of an HIV outbreak in Indiana, researchers found that by September 2016, 205 out of about 4,400 people in the area had been diagnosed with HIV. They discovered that the infection likely started in 2011, intensified in 2014, and slowed down after health officials declared a public emergency. It's crucial to act quickly to identify new infections and stop the disease from spreading among people who inject drugs. Who this helps: This helps patients and public health officials working to prevent HIV outbreaks.

Plain English
The study looked at 234 children and young people in the US who were born with HIV. It found that 75% of them had resistance to antiretroviral medications, which is much higher than the typical rate of 36% to 44% found in other patients. This is important because it means that these young individuals may not respond well to standard HIV treatments, especially if they have high viral loads. Who this helps: This information benefits doctors working with young HIV patients and the patients themselves, as it highlights the need for tailored treatment approaches.

Plain English
This study looked at a new way to test for HIV-1 types in women, using DNA from their blood cells, especially when their virus levels are low. Researchers found that 33% of DNA samples showed a different type of HIV than what was seen in their blood plasma samples, which showed 24% at the start. This matters because it helps doctors decide if patients can switch to certain treatments that target specific types of HIV, ensuring they receive the best care possible. Who this helps: Women living with HIV-1 who are undergoing treatment.

Plain English
This study looked at two ways to test HIV types (genotypic and phenotypic testing) in people who have never received treatment before. Out of 304 participants, both tests agreed on the type of HIV in about 80% of cases, with the genotypic test being slightly more accurate because it classified 18% of samples as a specific type of HIV compared to 16% by the other test. This is important because it shows that the genotypic test can be a reliable option for determining HIV type, which helps guide treatment decisions. Who this helps: This benefits doctors and patients by providing a reliable testing method for HIV treatment planning.

Plain English
This study focused on a new test that checks how HIV-1 infects cells, which is important for deciding if certain treatments can be given to patients. Researchers tested samples from 42 patients and found that the new test using proviral DNA agreed with standard tests on HIV RNA about 93% to 98% of the time. This is significant because it means that even patients whose HIV is suppressed can be evaluated for treatment options effectively. Who this helps: This helps HIV patients who are stable but need to find out if they can use specific therapies.

Plain English
This study focused on a new genotypic test for determining the type of HIV-1 virus in patients before they start a specific treatment called maraviroc. Researchers found that this test can effectively distinguish between patients with two virus types—those with CCR5 (R5) and those with CXCR4 (non-R5) variants. The results were significant, showing that R5 patients experienced a greater reduction in viral load at week 8 compared to non-R5 patients, with changes of -2.4 for R5 compared to -1.2 or -1.0 for non-R5, indicating this testing method could better inform treatment decisions. Who this helps: This benefits HIV patients who need treatment, ensuring they receive the most effective therapy for their specific virus type.

Plain English
This study focused on understanding drug resistance in hepatitis B virus (HBV) treatments, especially how mutations in a key enzyme (reverse transcriptase) affect treatment effectiveness. The researchers analyzed nearly 24,000 HBV sequences and found that a significant number of individuals (27%) had received treatment, with several mutations linked to resistance against specific drugs like lamivudine and adefovir. This knowledge is crucial for improving treatment strategies and ensuring patients receive effective therapies. Who this helps: This helps patients and doctors manage hepatitis B treatment more effectively.

Plain English
This study focused on a specific mutation in the HIV virus called Q145M and its effect on treatment with certain medications. Researchers found that this mutation does not make the virus resistant to the drugs that target reverse transcriptase, which means patients can still effectively use these treatments. This is important because it means that doctors can continue to prescribe these medications without worrying that this particular mutation will render them ineffective. Who this helps: Patients living with HIV who rely on reverse transcriptase inhibitors.

Plain English
Researchers studied specific changes in the HIV-1 virus that could make it less responsive to the drug etravirine. They found that certain combinations of mutations significantly lowered the virus's susceptibility to the drug, with reductions reported as high as 1,400 times in some cases. Understanding these mutations helps improve treatment strategies for people living with HIV and ensures they receive the most effective medications. Who this helps: This benefits patients living with HIV who need effective treatment options.

Plain English
This study examined how certain HIV strains have changed in order to resist the drug darunavir, which is used to treat HIV. The researchers found that these resistant strains had significant mutations—18 to 21 changes in their structure—and their ability to bind with darunavir was reduced, showing only about 5% of the normal enzyme's efficiency. Understanding these changes is important because it helps doctors tailor treatments for patients whose HIV has become resistant to darunavir. Who this helps: This helps patients with HIV, especially those facing treatment challenges due to drug resistance.

Plain English
This study focused on two genetic changes in the HIV-1 virus, called E40F and K43E, to understand how they affect the virus's ability to resist a common treatment. Researchers found that E40F significantly increases resistance to the drug Zidovudine by nine to fourteen times, but it also makes the virus less capable of replicating. In contrast, K43E helps the virus replicate better when it’s combined with E40F, acting as a compensatory change. Who this helps: This research helps doctors better understand how HIV can resist treatments, improving patient care and management strategies.

Plain English
This study looked at how certain changes in the HIV virus can make it resistant to treatments called protease inhibitors (PIs). Researchers found that insertions of specific amino acids at positions 33 and 35 in the virus's protease enzyme make it harder for these treatments to work; these changes have become more common in patients undergoing long-term PI therapy. Understanding these mutations helps in developing better treatment strategies to combat resistant strains of HIV. Who this helps: This information benefits doctors and HIV patients who need effective treatment options.

Plain English
In this study, researchers looked at a specific mutation in the HIV virus (called I47A) that makes it harder for the drug lopinavir to work. They found that this mutation significantly increases the virus's resistance to the drug, with the level of resistance being 100 times higher compared to the standard version of the virus. Understanding this mutation helps in treating patients by allowing doctors to better tailor antiviral therapies to overcome drug resistance. Who this helps: This information benefits patients with HIV who may be struggling to respond to treatment.

Plain English
Researchers studied the transmission of a highly resistant strain of HIV from one man in New York City to his partner, which led to rapid progression to AIDS in the first man and the development of a new resistant strain in the second man. They found that the primary strain (CT01) had characteristics that allowed it to resist multiple treatments, leading to severe health consequences. This research highlights the dangers of unprotected sex between partners with different HIV statuses and the potential for creating even more resistant strains of the virus, which complicates treatment. Who this helps: This helps patients and healthcare providers by emphasizing the need for safe sex practices and monitoring for drug-resistant strains of HIV.

Plain English
This study looked at specific mutations in the HIV virus that affect how well the virus responds to treatment. Researchers found that the K70E mutation was present in 10% of patients who did not respond to a certain combination of drugs, while a combination of K65R and K70E led to a significant drop in the virus's ability to replicate, down to just 0.01%. These findings help understand how certain mutations make HIV more resistant to treatments, which is crucial for developing effective therapies. Who this helps: This helps patients with HIV by informing doctors on how to choose the best treatments.

Plain English
This study looked at how long-term treatment with protease inhibitors (a type of drug for HIV) is linked to the development of mutations in the virus that make the drugs less effective. Researchers found that after more than four years of treatment, 24 new mutations became more common, while three decreased in prevalence. This is important because it shows that long-term use of these drugs can increase resistance, making it harder to treat HIV effectively. Who this helps: Patients with HIV, particularly those on long-term protease inhibitor therapy.

Plain English
This study looked at specific genetic changes in HIV-1, focusing on two rare amino acid inserts near an important site in the virus's reverse transcriptase enzyme. Researchers found that these changes made the virus less responsive to two common treatments, efavirenz and nevirapine, in infected individuals. Understanding how these genetic changes affect treatment resistance is important because it helps doctors choose the most effective therapies for patients with this particular strain of HIV. Who this helps: This helps patients with HIV who may be resistant to standard treatments.

Plain English
This study looked at a specific mutation (I47A) in the HIV-1 protease enzyme, linked to resistance against the drug lopinavir. Researchers found that this mutation appeared in 99 out of over 112,000 samples tested after lopinavir was available, showing that it dramatically increased resistance to the drug (86 to over 110 times) while making the virus more susceptible to another drug, saquinavir (0.1 to 0.7 times). Understanding this mutation is important because it highlights how HIV can adapt to treatments, helping doctors choose more effective therapies for their patients. Who this helps: This helps patients living with HIV and their healthcare providers.

Plain English
Researchers studied a new two-amino acid change in the HIV-1 protease gene from a person who was not responding to a type of treatment called protease inhibitors. They discovered that this new change did not make the virus any less susceptible to these drugs compared to other strains that had similar resistance problems. This finding is important because it shows that this specific mutation does not necessarily lead to treatment failure in patients on protease inhibitors. Who this helps: This helps doctors treating patients with HIV.

Plain English
The researchers studied how changes in the structure of the HIV-1 virus can affect its resistance to specific medications known as protease inhibitors. They developed a computer program that predicts how well these drugs bind to mutated versions of the virus, finding a strong correlation between the predicted binding strength and the actual effectiveness of the drugs against those mutations. This method showed about 92% accuracy in predicting drug resistance compared to traditional lab tests. Who this helps: This helps doctors and patients by improving the ability to predict drug resistance in HIV treatments.

Plain English
This study looked at a potential quality issue with ultrasensitive tests that measure HIV viral load, specifically focusing on how often patients showed low levels of the virus. Researchers found that there were instances of patients having low-level viremia, which raises concerns about the reliability of these test results. This matters because accurate measurements of viral load are crucial for ensuring effective treatment and monitoring of HIV. Who this helps: This helps patients living with HIV and their doctors.

Plain English
This study looked at a new genetic change in HIV-1 that added a 15-base pair segment to a specific part of the virus's reverse transcriptase gene. The researchers found that this change made the virus significantly more resistant to several medications: 371 times more resistant to zidovudine, 84 times to lamivudine, and varying increases for other drugs as well. This finding is important because it shows a new way the virus can adapt and become resistant to treatment while maintaining its ability to survive. Who this helps: This benefits patients by helping doctors understand how HIV can become resistant to treatments.

Plain English
Researchers studied HIV samples from over 24,000 patients and found 24 cases where the virus had a small insert in a specific gene called the protease gene. Their analysis showed that these inserts were made of 1 to 6 amino acids and often reduced the virus's resistance to certain treatments. Most importantly, viruses with these inserts grew slightly better than those without, indicating that while these mutations can happen, they don't necessarily make the virus much stronger against medications. Who this helps: This helps patients living with HIV by improving understanding of how certain mutations affect treatment options.

Plain English
This study looked at a protein repair enzyme that helps fix damaged proteins in many living organisms, from bacteria to humans. Researchers found that this enzyme changes very slowly over time, with a rate of 0.39 changes in its building blocks for every billion years, indicating it is highly conserved. This slow change is important because it suggests the enzyme must maintain its specific function of recognizing and repairing damaged proteins effectively across different species. Who this helps: This information benefits scientists studying protein damage and aging, as well as patients with conditions related to protein repair.

Plain English
This study looked at a specific protein repair process in tiny worms called Caenorhabditis elegans and how a lack of a certain enzyme affects their survival. The researchers created worms that couldn’t produce this enzyme and found that, while the adult worms lived normally, those in a dormant stage (dauer) survived only about 3.5 times less than regular worms after 50 days. This is important because it shows that without this enzyme, the worms struggle to survive in a stressed state, which could help us understand how aging and protein damage affect wellness in other organisms, including humans. Who this helps: This helps researchers and doctors studying aging and protein repair in humans.

Plain English
Researchers studied a protein called L-isoaspartyl methyltransferase in the nematode worm Caenorhabditis elegans, which helps repair damaged proteins as the worm ages. They found that the levels of this enzyme increase twofold when the worm enters a special developmental stage called the dauer larval form, which allows it to survive for long periods. This discovery matters because it highlights how certain proteins can help organisms cope with aging, and may provide insights into similar mechanisms in humans. Who this helps: This benefits researchers and doctors working on aging and protein repair therapies.

Plain English
This study looked at specific patterns, called motifs, in a group of enzymes that use a molecule called S-adenosylmethionine to add methyl groups to various substances. Researchers discovered three key motifs present in many of these enzymes: 69 of 84 studied sequences had one known as motif I, while 46 had motif II, and 61 had motif III. Identifying these shared regions is important because they may help understand how these enzymes work and could enhance the search for similar enzymes in genetic studies. Who this helps: This benefits researchers and scientists working on gene sequencing and enzyme function.

Plain English
This study looked at two types of a specific protein involved in breaking down certain amino acids in human blood. Researchers found that these two proteins have slight differences, particularly at the end, where one has a sequence (-RWK) and the other has a different sequence (-RDEL), which is important for how proteins are located within cells. This discovery is significant because it suggests that the variations of this protein could help explain differences in how the body processes amino acids and may lead to the identification of a third type of protein. Who this helps: This research benefits patients with conditions related to amino acid metabolism, as understanding these proteins may improve treatment options.

Plain English
Researchers studied two forms of a protein that helps manage specific chemicals in red blood cells. They found that while the proteins are similar in many ways, they have a key difference at the end of their structure: one form has a certain pair of amino acids that the other does not. This discovery is important because understanding these differences can help clarify how these proteins function in the body and how they may be involved in diseases. Who this helps: This helps patients with blood-related disorders and researchers looking into protein functions.

Plain English
This study looked at families who were able to avoid putting their children in institutional care compared to those who couldn't. The researchers found specific traits of families and children that were linked to success, helping to identify what makes a home-based counseling program effective. Understanding these factors is important because it can guide future programs to help more families keep their children at home. Who this helps: This helps families and social workers involved in child welfare.

Plain English
This study looked at ways to help young people who were ordered by the court to get support instead of being sent to a facility. By placing these youths in short-term foster homes and involving their families in counseling, the program saw positive responses from parents and a significant drop in the number of youths needing institutional care—from higher numbers down to much lower levels. This matters because it shows that family involvement can lead to better outcomes for troubled youth. Who this helps: This helps families and young people facing legal issues.

Plain English
This study looked at the challenges and important factors involved in adopting emotionally disturbed young people by analyzing 78 children and teenagers who were placed with adoptive families between 1974 and 1982. The findings highlight the key elements that influence successful adoptions for these hard-to-place youths. Understanding these factors is crucial as it can improve future adoption processes and support for families taking in these children. Who this helps: This helps adoptive families and social workers.

Plain English
This research explores how to support children in foster care who often push people away. The study looks at the reasons behind their challenging behavior by considering the child's view and the family's situation. This approach helps caregivers understand and manage these children better, creating a more positive environment for everyone involved. Who this helps: This benefits foster children and their caregivers.